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Epidemiology: (include definition, how diagnosed, risk factors, patterns, causes,
effects of disease, affected populations as necessary)
New-onset seizure activity in an otherwise healthy child without fever is a relatively common
occurrence in the pediatric population. In fact, every year in the US alone, 25,000-40,000
children experience a first-time nonfebrile seizure and 1/10 people will experience a single
seizure in their lifetime. Most of these children are well appearing at the time of presentation with
no lateralizing signs on neurological examination and as such, some providers may not be
motivated to perform invasive procedures without clear evidence to support such investigation.
The primary aim of this CPG was to highlight the evidence regarding diagnostic evaluation and
management of these children to help avoid unnecessary testing and imaging, particularly
because 75% of these otherwise neuro-developmentally normal children will not experience
recurrence. (Hirtz et al., 2003)
Objective of Guideline: The objective of this guideline, besides standardizing care and the
benefits associated with care standardization, is to reduce unnecessary testing and assure
appropriate follow-up is obtained.
Target Users: ED providers- physicians, fellows, resident physicians, advance practice nurses,
and direct care nurses.
Guideline Inclusion Criteria: Children 2 to 18-year-old, presenting after a first-time
unprovoked, afebrile seizure.
Guideline Exclusion Criteria: Children who have established epilepsy, children with ongoing
seizure activity when they are admitted to the ED, children who were treated with a medication
by emergency medical services (EMS), children with atonic or myoclonic seizures, children who
are in status epilepticus. For this CPG, status epilepticus is defined as a series of seizure activity
that grouped together lasts >30 minutes or a single seizure lasting greater than 5 minutes that
has not resolved. This definition was attained by consensus of CM providers.
Clinical Questions Answered by Guideline:
Questions
1. For the child who presents to the emergency department (ED) after a first nonfebrile
seizure should laboratory studies be obtained as part of the acute evaluation?
2. For the child who presents to the ED after a first nonfebrile seizure should a lumbar
puncture to evaluate CSF be obtained as part of the acute evaluation?
3. For the child who presents to the ED after a first nonfebrile seizure should an
electroencephalogram (EEG) be obtained as part of the acute evaluation?
4. For the child who presents to the ED after a first nonfebrile seizure should a computed
tomography (CT) be obtained as part of the acute evaluation?
5. For the child who presents to the ED after a first nonfebrile seizure should a magnetic
resonance imaging (MRI) be obtained as part of the acute evaluation?
6. For the child who presents to the ED after a first nonfebrile seizure should the child be
admitted to the hospital?
7. For the child who presents to the ED after a first afebrile seizure what anticipatory
guidance should be offered to families?
8. For the child who presents to the ED after a first afebrile seizure what follow-up should
be arranged?
Principles of Clinical Management:
In the evaluation of a child who presents after a first-time seizure the primary goal is to
determine whether the event was provoked, as this has implications for estimating recurrence
risk. The following elements should be elicited from the history:
 Is there any history suggestive of a possible electrolyte disturbance?
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Examples: vomiting, diarrhea, missed feeds or altered concentrations of feeds,
known underlying condition with associated electrolyte abnormalities (Type I
diabetes, congenital adrenal hyperplasia (CAH), kidney disease, etc)
Is there any history suggestive of an ingestion?
Examples: medication overdose, accidental ingestion, new or changed prescriptions,
periods of time when a child might have been unattended and around accessible
medications
Is there any history to suggest head trauma?
Examples: fall, non accidental trauma (NAT), etc
Is there any underlying history of epilepsy, provoked seizures, or febrile seizures?

The following physical exam findings may also be suggestive of an underlying source of
provocation for seizure:
 Stigmata of a neurodevelopmental disorder: dysmorphic features, neurocutaneous
markers
 Obvious signs of trauma (bruising, fractures, bleeding, etc)
* Note: This guideline is not intended for children who have ongoing seizure activity at
the time of presentation or who fail to return to their neurological baseline
The differential diagnosis for seizure includes the following:
Syncope, convulsive syncope
Complicated migraine or migraine with aura
Gastrointestinal disorders (reflux)
Psychiatric conditions (panic attacks, psychogenic non-epileptic events)
TIA
Movement disorders
Breath holding spells
Sleep disorders (night terrors, cataplexy)
Stereotypies (hand flapping)
If the child’s history and/or physical examination are suggestive of a provoked seizure, or the
child has been given a medication to stop the seizure, this child goes Off Guideline and work-up
will be tailored individually for each clinical scenario. Diagnostic studies could include but are not
limited to serum electrolytes, serum drug levels, urine toxicology screen, coagulation profile,
troponins, EKG, plain films, CT scans, etc.
Regarding our own experience at Children’s Mercy Hospital (Zuccarelli & Hall (2014), 133 patients
presenting with a first-time nonfebrile seizure, electrolytes were obtained in 13 of 14 (93%)
children with a history suggestive of an underlying abnormality but also in half of children with a
reassuring history (62 of 119, 52%). Importantly, no child with an unremarkable history and
exam was found to have electrolyte abnormalities falling below levels most likely to be associated
with acute symptomatic seizures (Na <115 mEq/L, glucose <40 mg/dL, Ca <5 mg/dL). Using
even more conservative reference ranges (Na <135 mEq/L, glucose <60 mg/dL and Ca <8.5
mg/dL), 56 of 62 children (90%) with an unremarkable history and exam had normal results, and
abnormal results did not change clinical management for any of these children.
Follow-up- While 75% of otherwise healthy, typically developing children with a first-time
nonfebrile seizure will not experience recurrence, 25% of these children may experience another
nonfebrile seizure. As such, we recommend all children be referred for outpatient routine EEG to
evaluate for an underlying seizure tendency. If the EEG returns abnormal, the child is at a higher
risk for seizure recurrence and the family should be counseled regarding antiepileptic therapy.
The child may follow-up with their pediatrician if the EEG is normal. Because seizures are
common, occurring in 1 in 10 individuals, while epilepsy is much less common, occurring in 1 in
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100 individuals, automatic follow-up with a subspecialist, a pediatric neurologist, is not
necessarily warranted, particularly if the EEG is normal.
Outcome Measures:
The following outcome measures have been identified:
1. PowerPlan use
2. Laboratory tests obtained
a. BMP
b. CBC with Diff
c. Blood Glucose Monitoring POC
3. Radiologic tests obtained
a. CT without contrast & CT with + without contrast
b. MRI without contrast
4. Follow-up EEG order placed
5. Return to ED within 72 hours with same condition
6. Hospital Admission
Potential Cost Implications: The goal of the EDP First Seizure Management CPG is to reduce
the cost by decreasing unnecessary interventions for this population. In 1992, a national cost
analysis (Nypaver, Reynolds, Tanz, & Davis, 1992) was last performed in this patient population,
the average cost per child for laboratory work-up alone was $122, which today would be closer
to $200.
Potential Organizational Barriers:
Education
Parental expectations
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PowerPlan:
Unique Plan Description: EDP First Nonfebrile Seizure
Plan Selection Display: EDP First Nonfebrile Seizure
PlanType: ED/UCC
Version: 1
Begin Effective Date: 03/11/2016 08:36
End Effective Date: Current
Available at all facilities
EDP First Nonfebrile Seizure
Consults/Therapy
CPG recommendation (NOTE)*
Clinic Referral Neurology Clinic
Neurology Clinic, First-time nonfebrile seizure
EEG Request
This patient was evaluated for a first-time nonfebrile seizure.
*Report Legend:
DEF - This order sentence is the default for the selected order
GOAL - This component is a goal
IND - This component is an indicator
INT - This component is an intervention
IVS - This component is an IV Set
NOTE - This component is a note
Rx - This component is a prescription
SUB - This component is a sub phase
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Guideline Preparation: This guideline was prepared by The Office of Evidence Based Practice
(EBP) in collaboration with content experts at Children’s Mercy Hospitals and Clinics.
Development of this guideline supports the Department of Clinical Effectiveness’s initiative to
promote care standardization that builds a culture of quality and safety that is evidenced by
measured outcomes. If a conflict of interest is identified the conflict will be disclosed next to the
team members name.
First Seizure Management in the ED CPG Team Members:
 Amy D’Angelo, MD, Emergency Medicine
 Andrew Loehr, RN
 Brian Burghardt, MD, General Pediatrics
 Emily Dague, RN, CPNP Emergency Department and Urgent Care
 Marcie Goeden, MD, Pediatric Resident, Neurology
 Ara Hall, MD, Epileptologist, Neurology
 Jan Wiebe, RN, CPN, SANE-A, SANE-P, Emergency Department Director of Nursing
 Amanda Montalbano, MD, MPH, QBS
 Kiran Raman, MD
 Ibad Siddiqi, PharmD, Emergency Department Pharmacist
 Britton Zuccarelli, MD, Neurology Fellow
Evidence Based Practice Scholars:
 Lynda Bainbridge, RN, MBA
 Teresa Bontrager, RN, BSN, MSNed, CPEN
 Jamie Cailteux, RN, BSN, CPN
 Kate Collum, RN, BSN
 Jennifer Foley, RT(R)(N), CNMT
 Anne Holmes, RN, MSN, MBA-HCM, CCRC
 Patty Lanzer RN, NNP-BC
 Andrea Melanson, OTD, OTR/L
Office of EBP Team Members:
 Jeffery Michael, DO Medical Director, Office of Evidence Based Practice
 Jacqueline Bartlett, PhD, RN Director Office of Evidence Based Practice
 Nancy Allen, MS, MLS, RD, LD Evidence Based Practice Research Specialist
 Jarrod Dusin, MS, RD, LD, CNSC
Guideline development funded by:
No external funding was obtained in the development of this guideline.
Development Process:
The review summary documents the following steps:
1. Review of existing internal and external guidelines and standards
a. Internal guidelines: None
b. External guidelines(Adams & Knowles, 2007) and (Hirtz et al., 2000)
2. Review preparation
a. PICOT questions established
b. Team leaders confirmed search terms used by the librarians in the Health Sciences
Libraries. The team leaders also reviewed article titles and abstracts form the searches
and identified the articles to be read and synthesized by the Evidence Based Practice
Scholars.
3. Databases searched
a. AHRQ National Guideline Clearinghouse
b. Medline
c. Cochrane
4. Critically analyze the evidence
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a. Guidelines
i.
AGREE criteria were used to analyze published clinical guidelines
b.
Single studies
i.
The EBP Scholars used the Cochrane Collaborative’s electronic
software, Review Manager 5 (RevMan), to produce systematic reviews and
meta-analysis of the evidence of the effects of healthcare and delivered these
documents to the team for review. RevMan allowed the EBP Scholars to build
the tables of study characteristics, tables of study biases, and analyze study
data in a meta-analysis. . In instances when RevMan could not be used, CASP
(Critical Appraisal Skills Programme) tools were utilized to analyze the literature.
c. When a meta-analysis was found in the literature search, or created in RevMan, the
GRADE criteria evaluated the literature using the Cochrane Collaborative’s
electronic software known as GRADEprofiler (GRADEpro). GRADEpro assesses
the meta-analysis for:
1.
Limitations in study design and execution
2.
Inconsistency between studies
3.
Indirectness of study outcomes
4.
Imprecision
5.
Publication bias
ii.
Table 1 defines how the quality of the evidence is rated and how the
recommendation is established based on the type of evidence.
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iii.
Table 1. Grading of CPG Recommendations
Grade of
Confidence in
Recommendation
Clarity of
Benefits vs.
Harms, Burden,
and Cost
Strong recommendation Desirable effects
High quality evidence
clearly outweigh
undesirable effects
or vice versa

Quality of
Supporting
Evidence

Implications

Consistent evidence
from well-performed
RCTs or exceptionally
strong evidence from
unbiased
observational studies

Recommendation can
apply to most patients
in most circumstances.
Further research is
unlikely to change our
confidence in the
estimate of effect
Recommendation can
apply to most patients
in most circumstances.
Further research (if
performed) is likely to
have an important
effect on our
confidence in the
estimate of effect and
may change the
estimate.
Recommendation may
change when higherquality evidence
becomes available.
Further research (if
performed) is likely to
have an important
influence on our
confidence in the
estimate of effect and
is likely to change the
estimate.
Recommendation may
change when higherquality evidence
becomes available;
any estimate of effect,
for at least 1 critical
outcome, is uncertain.

Strong recommendation
Moderate-quality
evidence

Desirable effects
clearly outweigh
undesirable effect
or vice versa

Strong recommendation
Low-quality evidence

Desirable effects
clearly outweigh
undesirable effect
or vice versa

Strong recommendation
Very-low-quality
evidence
(Very rarely applicable)

Desirable effects
clearly outweigh
undesirable effect
or vice versa

Evidence for at least
1 of the critical
outcomes from
unsystematic clinical
observations or very
indirect evidence

Recommended
High-quality evidence

Desirable effects
closely balanced
with undesirable
effects

Consistent evidence
from well-performed
RCTs or exceptionally
strong evidence from
unbiased
observational studies
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Evidence from RCTs
with important
limitations
(inconsistent results,
methodological flaws,
indirect evidence, or
imprecise results) or
unusually strong
evidence from
unbiased
observational studies
Evidence for at least
1 critical outcome
from observational
studies, from RCTs
with serious flaws or
indirect evidence

The best action may
differ, depending on
circumstances or
patients or societal
values. Further
research is unlikely to
change our confidence

8

June 16, 2016
in the estimate of
effect.
Recommended
Moderate-quality
evidence

Desirable effects
closely balanced
with undesirable
effects

Evidence from RCTs
with important
limitations
(inconsistent results,
methodological flaws,
indirect evidence, or
imprecise results) or
unusually strong
evidence from
unbiased
observational studies

Recommended
Low-quality evidence

Desirable effects
closely balanced
with undesirable
effects

Evidence for at least
1 critical outcome
from observational
studies, from RCTs
with serious flaws or
indirect evidence

Recommended
Very-low-quality
evidence

Desirable effects
closely balanced
with undesirable
effects

Alternative approaches
likely to be better for
some patients under
some circumstances.
Further research (if
performed) is likely to
have an important
influence on our
confidence in the
estimate of effect and
may change the
estimate.
Other alternatives may
be equally reasonable.
Further research is
likely to have an
important influence on
our confidence in the
estimate of effect and
is likely to change the
estimate.
Other alternatives may
be equally reasonable.
Any estimate of effect,
for at least 1 critical
outcome, is uncertain.

Evidence for at least
1 critical outcome
from unsystematic
clinical observations
or very indirect
evidence
Adapted from: Schunemann, H. J., Vist, G. E., Jaeschke, R., Kunz, R., Cook, D. J., & Guyatt, G.
(2002). Advanced topics in moving from evidence to action: Grading recommendations. In
Guyatt, G., Rennie, D., Meade, M. O., & Cook, D. J.(Ed.), Users’ guides to the medical literature:
A manual for evidence-based clinical practice (pp 679-701). New York, NY:McGraw-Hill.
5. Recommendations for the guideline were developed by a consensus process incorporating
the three principles of EBP (current literature, content experts, and patient and family
preference [when possible])

Approval Process: Guidelines are reviewed by Bradley L. Schlaggar, MD, PhD Neurologist-in
Chief, & Adam Ostendorf, MD, Fellow in Pediatric Fellow, both of St Louis Children’s, Content
Expert Team at Children’s Mercy, the Office of EBP, and other appropriate hospital committees as
deemed suitable for the guidelines intended use. Guidelines are reviewed and updated as
necessary every 3 years within the Office of EBP at CMH&C. Content expert teams will be
involved with every review and update.
Disclaimer:
The content experts and the Office of EBP are aware of the controversies surrounding First
Seizure CPG When evidence is lacking or inconclusive, options in care are provided in the
guideline and the power plans that accompany the guideline.
These guidelines do not establish a standard of care to be followed in every case. It is recognized
that each case is different and those individuals involved in providing health care are expected to
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use their judgment in determining what is in the best interests of the patient based on the
circumstances existing at the time.
It is impossible to anticipate all possible situations that may exist and to prepare guidelines for
each. Accordingly, these guidelines should guide care with the understanding that departures
from them may be required at times.
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Reason for Exclusion
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Author, date,
country, and
Patient Group
industry of
funding
Overview of Diagnostic Work up
(Hirtz et al.,
Children and
2003)
adolescents
with first
unprovoked
seizure

Strength of
Evidence
(GRADE)

Research design

-AAN Practice Parameter
The guideline
Guideline
was reviewed
by two team
members using
the AGREE
tool. The
consensus was
to accept the
guideline with
alterations

Significant results

Limitations

The Practice Parameter addresses the following:
Laboratory studies- may be obtained when history
or clinical findings such as vomiting, diarrhea, or
dehydration are present.
Lumbar puncture (LP)- should not be obtained
unless meningitis is suspected.
EEG- should be performed as part of the
evaluation of first non-febrile seizure. Timing of
the study (within the first 48 hours or later) is not
clear.
NeuroimagingCT scan- should not be obtained.
MRI- should not be obtained for the child with a
first non-febrile seizure who has returned to
baseline.

*Concerns with
the AAN
Guideline (Hirtz
et al., 2000)
include:
The development
group did not
include Pediatric
Emergency
Medicine,
patient/parent/fa
mily
representatives
Methods for
formulating the
recommendation
s, cost
implications and
conflicts of
interest are not
reported
transparently

62 subjects were enrolled- 50% male
9 subjects had leukocytosis (14.5%), a second
CBC was obtained and leukocytosis did not
persist.

Small number of
subjects.

Should Laboratory Studies be Obtained?
(Aydogan,
Aydogan,
Kara,
Basim, &
Erdogan,

Children mean
age 4 ±3.6 y
(range 6 m13 y)
Presenting

Very low
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Prospective cohort
All subjects with
afebrile seizure
between Jan
2000 and March
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Author, date,
country, and
industry of
funding
2007)
Turkey

(Landau,
Waisman,
& Shuper,
2010)
Israel

(Nypaver,
Reynolds,
Tanz, &
Davis,
1992) 1
USA

Patient Group

Strength of
Evidence
(GRADE)

with first
afebrile
seizure

85 subjects
average
age 7.5 y
(range 0-18
y) who
made 104
visits to the
ED
Excluded
febrile
seizure or
other
primary
diagnosis
308 ED
charts,
108 febrile
(mean age
2.1 years)
200 non
febrile
seizures.
(mean age
5.7 years

Research design
2002 were
enrolled

Very Lowinconsistent
includes
subjects that
do not apply
to this
guideline

Retrospective
chart review

Very Low

Retrospective
chart review

The Office of Evidence Based Practice, 2016
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Significant results

Limitations

Leukocytosis was more prevalent in children with
status epilepticus
SE defined as a continuous seizure lasting longer
than 30 minutes or repeating seizures last 30
minutes with recovering consciousness between
them.
Laboratory tests were obtained in 84% of visits.
Eight percent provided useful information and <
5% were helpful in diagnosis and management.
Only one lumbar puncture was performed.
Eight percent of visits had electrocardiography
performed and all were normal
Seven percent of visit had electroencephalography
performed and was consistently useful and was
always performed along with a neurology
consultation

41 were having their first non febrile seizure. 26
subjects (63%) had at least one laboratory test
performed.
No changes in therapy were made as the result of
the laboratory findings.
In 1992 US dollars, the mean cost of the
laboratory tests was $122.00 per subject.

Mix of children
with first seizure
and those already
on medication for
seizure. Only 30
(35%) subjects
presented with
first seizure.

Small sample size.
Important changes
in newborn
screening since
this study need to
be considered,
that is the need
for lab studies
may be even
lower.
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Author, date,
country, and
industry of
funding

Scarfone 2000
USA

(Valencia et

Patient Group
Included lab
tests:
electrolytes
Calcium,
magnesium,
ammonia,
glucose,
Dextrostix
Infants < or
equal to 12
months of
age
presenting
to the ED of
a tertiary
care
children’s
hospital.
Serum
chemistry
results
were
classified as
normal,
outside of
range
normal and
clinically
significantly
abnormal
Urban

Strength of
Evidence
(GRADE)

Very Low

Research design

Retrospective
chart review

Significant results

Limitations

214 patient visits made by infants with febrile and
non febrile seizures.
134/214 were non-febrile seizures and
70 of these were a first seizure, or 52% of all
presenting non febrile seizures.
51 of 70 had lab drawn
8/51 (16%) had a clinically significant
abnormality.

Would expanded
newborn
screening change
any of this?

Is there a Working Group on Status Epilepticus
recommendation that serum chemistries should
be obtained for adults and children with status
epilepticus?

Very Low

The Office of Evidence Based Practice, 2016
Center of Clinical Effectiveness

Prospective chart

Total of 107 children met criteria.
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Author, date,
country, and
industry of
funding
al., 2003)

Patient Group

Strength of
Evidence
(GRADE)

hospital, All
children
unprovoked
seizure.
Prospective

Research design
review
Separated out
those with
history of
seizure from
those with first
seizure

Significant results

Limitations

Mean age 6.6 years (range 0.1-20 years).
58% male
42% Black
33% Hispanic
19% White
7% Other
75% (N=80) had previous seizures
68% of these were taking anti epileptic
medications
For those who had chemistries drawn
2/33 in the previous seizure group had abnormal
electrolytes
For those who had chemistries drawn 5/21 in the
no previous seizure group had abnormal
electrolytes.
Patients with abnormal electrolytes were
significantly younger (mean age 1.7 vs. 7.2
years) symptoms included vomiting or diarrhea,
or presented with a changed in mental status.

Should LP be obtained?
(Landau,
85 subjects
Waisman,
average
& Shuper,
age 7.5 y
2010)
(range 0-18
Israel
y) who
made 104
visits to the
ED

Very Lowinconsistent
includes
subjects that
do not apply
to this
guideline

The Office of Evidence Based Practice, 2016
Center of Clinical Effectiveness

Retrospective
chart review

Laboratory tests were obtained in 84% of visits.
Eight percent provided useful information and <
5% were helpful in diagnosis and management.
Only one lumbar puncture was performed.
Eight percent of visits had electrocardiography
performed and all were normal
Seven percent of visit had electroencephalography
performed and was consistently useful and was

Mix of children
with first seizure
and those already
on medication for
seizure. Only 30
(35% )subjects
presented with
first seizure

16

June 16, 2016
Author, date,
country, and
industry of
funding

(Lateef et al.,
2008)
USA

(Chan et al.,
2010)
Singapore

Patient Group
Excluded
febrile
seizure or
other
primary
diagnosis
Children 1- 6
months
with new
onset
seizures
N= 141

Children aged
1 month to
15 years
with first
afebrile
seizure
108 with ≥ 2
afebrile
seizure and

Strength of
Evidence
(GRADE)

Research design

Significant results

Limitations

always performed along with a neurology
consultation

Very Low
Cohort
study, small
number of
subjects, not
all had
results of
HSV or
enteroviral
infection

Prospective cohort

Very Low

Population Survey

The Office of Evidence Based Practice, 2016
Center of Clinical Effectiveness

Diagnostic standards of infected CSF
 WBC > 6 mm3
 Protein elevation > 50 mg/dl
 Positive bacterial culture
 Herpes simplex virus (HSV) PCR
76/141 (54%) underwent LP.
Age was the greatest factor in obtaining an LP.
Subjects aged 1-2 mo 70% LP whereas aged 56 mo 33 % LP
There was no relationship between presence of
CSF abnormalities and the final diagnosis of
seizure. At the time of discharge, 53% of those
who had an abnormal CSF were thought to
have a seizure, while the remaining 47% were
thought to have a non-seizure event.
1st SZ Epileps
y≥ 2
P value
SZ
Develo
pmental
P=0.04
93%
87%
exam
6
(norma
l)

LP is only
performed on
subjects whom
the attending
provider deems
necessary
Small population

Population based
study that looked
at the
epidemiology of
afebrile seizure.
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Author, date,
country, and
industry of
funding

Patient Group

Strength of
Evidence
(GRADE)

Research design

103 with
first afebrile
seizure

Should EEG be obtained?
(Arthur et al.,
Children age
2008)
6-14 years
USA
N= 150
(349 were
recruited)
Single afebrile
seizure
followed up
at 9, 11 and
27 months.
Provider
decided who
got MRI

Significant results
Neuro
exam
(norma
l)
EEG
(abnl)
CT/MRI
(abnl)

Low

The Office of Evidence Based Practice, 2016
Center of Clinical Effectiveness

Prospective cohort
Followed for at
least 27 months
Children with
absence,
myoclonic or
prior
unrecognized
seizure were
excluded.

98%

92%

P=0.01
6

36.9
%

75%

P≤0.00
5

33%

20.3%

NR

There was a recurrence rate of 66.4%
An abnormal EEG had no association with seizure
recurrence at 9, 18, or 27 mo (p = 0.1806, p =
0.2792, and
p =0.2379, respectively)
Recur By (%)
9 mo 18
27
mo
mo
Normal EEG
50.9
56.4
60
n=55
Abnl EEG
62.1
65.3
69.5
n= 95
Normal MRI
59.8
65.5
67.8
n=87
Non signif.
MRI
33.3
33.3
44.4
n=18
Signif. MRI
80
80
80
n= 20
A “significant” MRI abnormality (16% of subjects)
was associated with increased risk of recurrence
at 9 mo (p = 0.0389), but not 18 or 27 months
They do not recommend MRI after first seizure,

Limitations

Of the 349
recruited into the
larger study, 189
subjects met the
criteria for this
study.
150 had EEG
performed
125 subjects had
MRI performed.
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Author, date,
country, and
industry of
funding

Patient Group

Strength of
Evidence
(GRADE)

(Chan et al.,
2010)
Singapore

Children aged
1 month to
15 years
with first
afebrile
seizure
108 with ≥ 2
afebrile
seizure and
103 with
first afebrile
seizure

Very Low

(Anand et al.,
2012)
United
Kingdom

128 children
mean age
6.5 years
(range 1
month to
17 years.

Very Low
Appears to be
an abstract
only

The Office of Evidence Based Practice, 2016
Center of Clinical Effectiveness

Research design

Population Survey

Retrospective
observational
cohort

Significant results
because it is not predictive.
1st SZ Epileps
y≥ 2
P value
SZ
Develo
pmental
P=0.04
93%
87%
exam
6
(norma
l)
Neuro
exam
P=0.01
98%
92%
(norma
6
l)
EEG
36.9
P≤0.00
75%
(abnl)
%
5
CT/MRI
33%
20.3%
NR
(abnl)
Video EEG (vEEG) was normal in 75 subjects
(59%)
Non-epileptic events were recorded in 8 subjects
(6%)
Idiopathic generalized epilepsy was diagnosed in
14 subjects (11%)
Generalized epilepsy with febrile seizure was
diagnosed in 2 subjects (2%)
A focal epilepsy was diagnosed in 29 subjects
(23%)
Sensitivity= 100
Specificity = 10
(+) predictive value = 85%

Limitations

Population based
study that looked
at the
epidemiology of
afebrile seizure.

34 subjects had
neurodevelopmen
tal problem, 11
subjects had a
family history of
epilepsy, and 13
had a history of
febrile seizure.
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June 16, 2016
Author, date,
country, and
industry of
funding
(Hamiwka,
Singh,
Niosi, &
Wirrell,
2007)

(Hsieh et al.,
2010)
USA

Patient Group

Children 1
month -17
years
Mean age- 8
years, =/- 5
years
N= 127
53% male
Seen in clinic
52 +/- 18
days after
first
encounter
Development
delay
present in
19 children
(15%)
Abnormal
neurological
exam was
present in
14 (11%)
317 infant
subjects
(range 1-24
months)
urban
population

Strength of
Evidence
(GRADE)
Very Low

Low It is a
cohort study
based on a
clinical
guideline.

The Office of Evidence Based Practice, 2016
Center of Clinical Effectiveness

Research design

Non randomized
prospective
cohort study of
children seen at
a First Seizure
Follow-up Clinic

Prospective cohort

Significant results
(-) predictive value= not estimable
24% events were felt to be non-epileptic (n= 31)
Primary event was syncope
74% were felt to be epileptic (n=94)
2% (2) were unclassifiable
Results of follow up EEG
All 94 children with an epileptic event had an EEG.
44 of these children (47%) had abnormalities
present, 53% did not.
Thirty children without an epileptic event had
EEGs. 93% had normal studies.
Over a one year follow up, 42 children (45%)
were diagnosed with epilepsy.

EEG (all subjects) abnormalities were found in half
CT (298/317 obtained) abnormalities were found
in a third
MRI (182/ 317 obtained) abnormalities were
found in 57%
Of the 193 normal CTs, 97 underwent MRI of
which 32 (33%) had an abnormal MRI

Limitations

Many of the
subjects (38%) in
this study did
indeed have a
prior seizure
event that was
unreported by
the referring
provider, or
unrecognized by
the
parent/caregiver
at the time of the
referral.

The majority had
more than one
seizure upon
presentation.
The incidence of
seizures lasting
longer than 20
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Author, date,
country, and
industry of
funding

Patient Group

Strength of
Evidence
(GRADE)

Research design

Significant results

Limitations
minutes was
8.5%
30 subjects had a
history of
prematurity.
Increased
likelihood of
obtaining an MRI
in younger
infants.

(Landau,
Waisman,
& Shuper,
2010)
Israel

85 subjects
average
age 7.5 y
(range 0-18
y) who
made 104
visits to the
ED
Excluded
febrile
seizure or
other
primary
diagnosis
Should a CT scan be obtained?
(Hsieh et al., 317 infant
2010)
subjects
USA
(range 1-24
months)
urban

Very Lowinconsistent
includes
subjects that
do not apply
to this
guideline

Retrospective
chart review

Laboratory tests were obtained in 84% of visits.
Eight percent provided useful information and <
5% were helpful in diagnosis and management.
Only one lumbar puncture was performed.
Eight percent of visits had electrocardiography
performed and all were normal
Seven percent of visit had electroencephalography
performed and was consistently useful and was
always performed along with a neurology
consultation

Mix of children
with first seizure
and those already
on medication for
seizure. Only 30
(35% )subjects
presented with
first seizure

Low- It is a
cohort study
based on a
clinical
guideline.

Prospective cohort

EEG (all subjects) abnormalities were found in half
CT (298/317 obtained) abnormalities were found
in a third
MRI (182/ 317 obtained) abnormalities were
found in 57%

The majority had
more than one
seizure upon
presentation.
The incidence of

The Office of Evidence Based Practice, 2016
Center of Clinical Effectiveness
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Author, date,
country, and
industry of
funding

Patient Group

Strength of
Evidence
(GRADE)

Research design

population

Kodaphanhad
eh 2006
Iran

125 subjects,
children
mean age
53 ±48
months
(range1 month-15
years)

Low

Sharma 2003
USA

500 subjects
with newonset
afebrile
seizure
median age

Low

The Office of Evidence Based Practice, 2016
Center of Clinical Effectiveness

Retrospective case
series –no control
group. Excluded
those with
seizures > 30
minutes or
electrolyte
abnormalities
Report on CT scan
and MRI within
the first hours of
arrival
Retrospective

Significant results

Limitations

Of the 193 normal CTs, 97 underwent MRI of
which 32 (33%) had an abnormal MRI

seizures lasting
longer than 20
minutes was
8.5%
30 subjects had a
history of
prematurity.
Increased
likelihood of
obtaining an MRI
in younger
infants.

Neuro-imaging was obtained in 119 subjects
(95%)
Emergent CT was performed in 108 (91%) and
MRI in 11 (9%)
Neuro-imaging was normal in 107 (90%) of
subjects.
Clinical significant results were found in 12
subjects (10%)
10 of the 12 subjects with abnormal findings had
abnormal neurological examination.

Study design.

Neuro-imaging was performed in 475/500. 25
subjects were not imaged.
Of the subjects who were scanned, CT was
performed in 454/475, and MRI was performed
in 21/475.
437/475 had neuro-imaging while in the ED. And

5/6 subjects who
fell in the low risk
group by partition
analysis had
abnormal findings
on
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Author, date,
country, and
industry of
funding

Patient Group

Strength of
Evidence
(GRADE)

Research design

(16 mo
range (0-21
years))

Should an MRI be obtained?
(Arthur et al.,
Children age
2008)
6-14 years
USA
N= 150
(349 were
recruited)
Single afebrile
seizure
followed up
at 9, 11 and
27 months.

Low

The Office of Evidence Based Practice, 2016
Center of Clinical Effectiveness

Prospective cohort
Followed for at
least 27 months
Children with
absence,
myoclonic or
prior
unrecognized
seizure were
excluded.

Significant results

Limitations

13 had neuro-imaging after the ED visit but
within 72 hours of the visit.
Normal imaging results were reported in 395/475
subjects. [83%]
Clinically insignificant results were reported in
42/475 [9%]
Clinically significant events were reported in
38/475 subjects [8%]
Using Partition analysis, 3 variables partitioned the
subjects into 4 groups
Variables
Presence of pre disposing condition, focality of the
seizure and age
Groups
Predisposing condition- High risk
No predisposing condition
Non-focal seizure- low risk
Focal seizure- age dependent
Age > 33 months low risk
Age < 33 months high risk

physical/neurolog
ical exam.
One subject
subsequently
diagnosed with
grey matter
heterotopias had
a normal physical
and neurological
exam.
Retrospective
design

There was a recurrence rate of 66.4%
An abnormal EEG had no association with seizure
recurrence at 9, 18, or 27 mo (p = 0.1806, p =
0.2792, and
p =0.2379, respectively)
Recur By (%)
9 mo 18
27
mo
mo
Normal EEG
50.9
56.4
60
n=55
Abnl EEG
62.1
65.3
69.5

Of the 349
recruited into the
larger study, 189
subjects met the
criteria for this
study.
150 had EEG
performed
125 subjects had
MRI performed.
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Author, date,
country, and
industry of
funding

Patient Group

Strength of
Evidence
(GRADE)

Research design

Provider
decided who
got MRI

(Chan et al.,
2010)
Singapore

Children aged
1 month to
15 years
with first
afebrile
seizure
108 with ≥ 2
afebrile
seizure and
103 with
first
afebrile
seizure

Significant results

Limitations

n= 95
Normal MRI
59.8
65.5
67.8
n=87
Non signif.
MRI
33.3
33.3
44.4
n=18
Signif. MRI
80
80
80
n= 20
A “significant” MRI abnormality (16% of subjects)
was associated with increased risk of recurrence
at 9 mo (p = 0.0389), but not 18 or 27 months
They do not recommend MRI after first seizure,
because it is not predictive.
Very Low

The Office of Evidence Based Practice, 2016
Center of Clinical Effectiveness

Population Survey
1st SZ
Develo
pmental
exam
(norma
l)
Neuro
exam
(norma
l)
EEG
(abnl)
CT/MRI
(abnl)

Epileps
y≥ 2
SZ

P value

93%

87%

P=0.04
6

98%

92%

P=0.01
6

36.9
%

75%

P≤0.00
5

33%

20.3%

NR

Population based
study that looked
at the
epidemiology of
afebrile seizure.
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Author, date,
country, and
industry of
funding
(Hsieh et al.,
2010)
USA

Patient Group

Strength of
Evidence
(GRADE)

Research design

Significant results

Limitations

317 infant
subjects
(range 1-24
months)
urban
population

Low-It is a
cohort study
based on a
clinical
guideline.

Prospective cohort

EEG (all subjects) abnormalities were found in half
CT (298/317 obtained) abnormalities were found
in a third
MRI (182/ 317 obtained) abnormalities were
found in 57%
Of the 193 normal CTs, 97 underwent MRI of
which 32 (33%) had an abnormal MRI

The majority had
more than one
seizure upon
presentation.
The incidence of
seizures lasting
longer than 20
minutes was
8.5%
30 subjects had a
history of
prematurity.
Increased
likelihood of
obtaining an MRI
in younger
infants.

Kodaphanhade
h 2006 Iran

125 subjects,
children
mean age
53 ±48
months
(range1 month-15
years)

Low

Neuro-imaging was obtained in 119 subjects
(95%)
Emergent CT was performed in 108 (91%) and
MRI in 11 (9%)
Neuro-imaging was normal in 107 (90%) of
subjects.
Clinical significant results were found in 12
subjects (10%)
10 of the 12 subjects with abnormal findings had
abnormal neurological examination.

Study design.

Rauch 2008

75 children

Very Low-

Retrospective case
series –no control
group. Excluded
those with
seizures > 30
minutes or
electrolyte
abnormalities
Report on CT scan
and MRI within
the first hours of
arrival
Retrospective

Below 12 years of age sedated for MRI

There was a 53%

The Office of Evidence Based Practice, 2016
Center of Clinical Effectiveness
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Author, date,
country, and
industry of
funding
USA

Sharma 2003
USA

Patient Group
aged 0-18
years
Included
those with
MRI at
admission
and afebrile
seizure

Strength of
Evidence
(GRADE)
quality study

500 subjects
with newonset
afebrile
seizure
median age
(16 mo
range (0-21
years))

The Office of Evidence Based Practice, 2016
Center of Clinical Effectiveness

Research design
cohort – chart
review. Excluded
genetic anomaly,
history of
seizure, CNS
pathology

Retrospective

Significant results

Limitations

71 subjects (95%) had LOS increased by one day
for the MRI
13 subjects (17%) had abnormal MRI results;
1/13 had an abnormal neurological exam
No changes in treatment based on the MRI
occurred.

fall in the number
of MRI obtained
from the first to
second year as the
results from the
quality project
were made known
and changed
practice.
5/6 subjects who
fell in the low risk
group by partition
analysis had
abnormal findings
on
physical/neurolog
ical exam.
One subject
subsequently
diagnosed with
grey matter
heterotopias had
a normal physical
and neurological
exam.
Retrospective
design

Neuro-imaging was performed in 475/500. 25
subjects were not imaged.
Of the subjects who were scanned, CT was
performed in 454/475, and MRI was performed
in 21/475.
437/475 had neuro-imaging while in the ED. And
13 had neuro-imaging after the ED visit but
within 72 hours of the visit.
Normal imaging results were reported in 395/475
subjects. [83%]
Clinically insignificant results were reported in
42/475 [9%]
Clinically significant events were reported in
38/475 subjects [8%]
Using Partition analysis, 3 variables partitioned the
subjects into 4 groups
Variables
Presence of pre disposing condition, focality of the
seizure and age
Groups
Predisposing condition- High risk
No predisposing condition

26

June 16, 2016
Author, date,
country, and
industry of
funding

Patient Group

Strength of
Evidence
(GRADE)

Research design

Significant results

Limitations

Non-focal seizure- low risk
Focal seizure- age dependent
Age > 33 months low risk
Age < 33 months high risk
Should the child be hospitalized?
No studies found.
Overview of treatment and anticipatory guidance AAN Practice Parameter 2003
(Hirtz, et al.),
Children and
The guideline
Guideline
No evidence that treating a child after a first
2003
adolescents
was reviewed
unprovoked seizure reduced the risk of either
with first
by two team
subsequent significant injury or sudden death.
unprovoked
members
The burdens of treating outweigh the benefit.
seizure
using the
The burden of treating after the first unprovoked
AGREE tool.
seizure include
The
 Daily medication
consensus
 Perception the child is ‘sick’
was to accept
 Ability to obtain health insurance
the guideline
 Ability to find day care
with
 In teens, driving privileges
alterations*
 In teens, teratogenicity

What is the research basis of anticipatory guidance?
(Arthur et al.,
Children age
Low
Prospective cohort

The Office of Evidence Based Practice, 2016
Center of Clinical Effectiveness

There was a recurrence rate of 66.4%

*Concerns with
the AAN Guideline
(Hirtz et al.,
2003) include:
 The
development
group did not
include Pediatric
Emergency
Medicine,
patient/parent/f
amily
representatives
 Methods for
formulating the
recommendatio
ns, cost
implications and
conflicts of
interest are not
reported
transparently
Of the 349
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Author, date,
country, and
industry of
funding
2008)
USA

(Hamiwka,
Singh,
Niosi, &
Wirrell,
2007)

Patient Group

Strength of
Evidence
(GRADE)

6-14 years
N= 150
(349 were
recruited)
Single afebrile
seizure
followed up
at 9, 11 and
27 months.
Provider
decided who
got MRI

Children 1
month -17
years
Mean age- 8
years, =/5 years
N= 127
53% male

Research design
Followed for at
least 27 months
Children with
absence,
myoclonic or
prior
unrecognized
seizure were
excluded.

Very Low

The Office of Evidence Based Practice, 2016
Center of Clinical Effectiveness

Non randomized
prospective
cohort study of
children seen at
a First Seizure
Follow-up Clinic

Significant results

Limitations

An abnormal EEG had no association with seizure
recurrence at 9, 18, or 27 mo (p = 0.1806, p =
0.2792, and
p =0.2379, respectively)
Recur By (%)
9 mo 18
27
mo
mo
Normal EEG
50.9
56.4
60
n=55
Abnl EEG
62.1
65.3
69.5
n= 95
Normal MRI
59.8
65.5
67.8
n=87
Non signif.
MRI
33.3
33.3
44.4
n=18
Signif. MRI
80
80
80
n= 20
A “significant” MRI abnormality (16% of subjects)
was associated with increased risk of recurrence
at 9 mo (p = 0.0389), but not 18 or 27 months
They do not recommend MRI after first seizure,
because it is not predictive.
24% events were felt to be non-epileptic (n= 31)
Primary event was syncope
74% were felt to be epileptic (n=94)
2% (2) were unclassifiable

recruited into the
larger study, 189
subjects met the
criteria for this
study.
150 had EEG
performed
125 subjects had
MRI performed.

Results of follow up EEG
All 94 children with an epileptic event had an EEG.
44 of these children (47%) had abnormalities
present, 53% did not.

Many of the
subjects (38%) in
this study did
indeed have a
prior seizure
event that was
unreported by
the referring
provider, or

28

June 16, 2016
Author, date,
country, and
industry of
funding

Patient Group

Strength of
Evidence
(GRADE)

Seen in clinic
52 +/- 18
days after
first
encounter
Development
delay
present in
19 children
(15%)
Abnormal
neurologica
l exam was
present in
14 (11%)

The Office of Evidence Based Practice, 2016
Center of Clinical Effectiveness

Research design

Significant results
Thirty children without an epileptic event had
EEGs. 93% had normal studies.
Over a one year follow up, 42 children (45%)
were diagnosed with epilepsy.

Limitations
unrecognized by
the
parent/caregiver
at the time of the
referral.
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